Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 11.60M | $ 16.04M | $ 21.25M | $ 9.92M | $ 10.70M |
Total Assets | $ 3.59B | $ 3.37B | $ 3.16B | $ 3.24B | $ 3.09B |
Total Debt | $ 1.14B | $ 1.06B | $ 1.02B | $ 1.00B | $ 913.50M |
Net Debt | $ 1.13B | $ 1.05B | $ 998.50M | $ 991.76M | $ 902.80M |
Total Liabilities | $ 1.32B | $ 1.23B | $ 1.18B | $ 1.19B | $ 1.09B |
Stockholders Equity | $ 2.27B | $ 2.13B | $ 1.97B | $ 2.05B | $ 1.99B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |